• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Definiens launches cloud-based digital pathology solution VeriTrova

Definiens launches cloud-based digital pathology solution VeriTrova

November 7, 2016
CenterWatch Staff

Definiens, a Tissue Phenomics solutions provider from biomarker discovery to meaningful diagnostics, has announced a program collaboration with Takeda Pharmaceuticals to enable comprehensive tissue-based analysis in clinical trials.

Definiens’ products and services deepen the understanding of disease biology and the immune system to advance clinical trials. By using knowledge-driven biomarker analysis in combination with VeriTrova, the company’s new cloud-based digital pathology platform, Definiens seamlessly translates research to clinical knowledge to the next generation of diagnostics.

As an early adopter of Definiens’ VeriTrova, Takeda will have the opportunity to leverage the platform to support its development programs.

“VeriTrova accelerates clinical trials through remote uploading and viewing of digitized IHC images from wet-lab partners and CROs to the cloud, where the images are analyzed,” says Thomas Colarusso, VP Business Development and Strategy at Definiens.

The real-time analysis is expected to help Takeda reduce normal processes from months to weeks, with image analysis providing a more automated and standardized readout.

“Takeda is dedicated to operational excellence and delivering high quality results in our clinical studies,” said Andrew Dorner, VP and global head of Translational Medicine at Takeda. “We expect this system will improve the timelines and quality of our image analysis for clinical biomarkers.”

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing